Pay in 4 interest-free payments of $10.50 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
A significant reduction of PCSK9 promoter activity by Anacetrapib (ANA) is detected at 3 µM concentration (−22%
is a potent inhibitor of CDK1/cyclin B (IC50 = 400 nM)
with mean decreases of 2
and ALK7 (> 0
Smiles: CC(C)C1=NC(=C2C(N)=NC=CN21)C1=CC=C(NC(=O)NC2=CC(=CC=C2)C(F)(F)F)C2=CC=CC=C21
UK-5099 - CAS# 56396-35-1 66052 A significant reduction of PCSK9UK 5099, CAS No. 56396 35 1, is a specific and potent mitochondrial pyruvate carrier blocker (MCK blocker). The UK5099 treated cells showed significantly higher proportion of side population (SP) fraction and expressed higher levels of stemness markers Oct3 4 and Nanog. Chemosensitivity examinations revealed that the UK5099 treated cells became more resistant to chemotherapy compared to the non treated cells. MPC blocker (UK5099) application may be an